201 related articles for article (PubMed ID: 21516557)
1. Special issue for dealing with multiplicity in drug development: current state and new directions--guest editors' note.
Dmitrienko A; Posch M
J Biopharm Stat; 2011 Jul; 21(4):581-2. PubMed ID: 21516557
[No Abstract] [Full Text] [Related]
2. ASCPT Task Force for advancing pharmacometrics and integration into drug development.
Goldberger MJ; Singh N; Allerheiligen S; Gobburu JV; Lalonde R; Smith B; Ryder S; Yozviak A
Clin Pharmacol Ther; 2010 Aug; 88(2):158-61. PubMed ID: 20648032
[TBL] [Abstract][Full Text] [Related]
3. Experiences with learning and confirming in drug and biological development.
Patterson SD
Clin Pharmacol Ther; 2010 Aug; 88(2):161-3. PubMed ID: 20648033
[TBL] [Abstract][Full Text] [Related]
4. Developing pharmacogenetic evidence throughout clinical development.
Burns DK
Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
[TBL] [Abstract][Full Text] [Related]
5. Special issue of statistical genetics and genomics in clinical trials: guest editor's note.
Wu R; Lin M
J Biopharm Stat; 2010 Mar; 20(2):191-2. PubMed ID: 20309753
[No Abstract] [Full Text] [Related]
6. Guest editors' introduction: special issue on sensor evolution.
Dautenhahn K; Polani D; Uthmann T
Artif Life; 2001; 7(2):95-7. PubMed ID: 11580875
[No Abstract] [Full Text] [Related]
7. Personalized therapy and pharmacogenomics: future perspective.
Siest G; Marteau JB; Visvikis-Siest S
Pharmacogenomics; 2009 Jun; 10(6):927-30. PubMed ID: 19530959
[No Abstract] [Full Text] [Related]
8. Guest editors' introduction to the special issue: mapping the terrain of emotional availability and attachment.
Easterbrooks MA; Biringen Z
Attach Hum Dev; 2000 Sep; 2(2):123-9. PubMed ID: 11707906
[No Abstract] [Full Text] [Related]
9. Pharmacogenetics in biological perspective.
Kalow W
Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
[TBL] [Abstract][Full Text] [Related]
10. Biostatistics and pharmacometrics: quantitative sciences to propel drug development forward.
Smith BP; Vincent J
Clin Pharmacol Ther; 2010 Aug; 88(2):141-4. PubMed ID: 20648027
[No Abstract] [Full Text] [Related]
11. Guest Editors' Note.
Cook B; Rumrill P
Work; 2000; 14(1):1. PubMed ID: 12441534
[No Abstract] [Full Text] [Related]
12. Guest editors' introduction. Preface.
Friede T; Henderson R; Hougaard P
Stat Med; 2014 Dec; 33(30):5221-2. PubMed ID: 25487915
[No Abstract] [Full Text] [Related]
13. Pharmacogenetics in drug discovery and development: a translational perspective.
Roses AD
Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
[TBL] [Abstract][Full Text] [Related]
14. Global drug discovery: Europe is ahead.
Light DW
Health Aff (Millwood); 2009; 28(5):w969-77. PubMed ID: 19706628
[TBL] [Abstract][Full Text] [Related]
15. Guest editors' note on special issue on real-world experience and randomized clinical trials.
Pan J; Lin DY
J Biopharm Stat; 2019; 29(4):579. PubMed ID: 31362612
[No Abstract] [Full Text] [Related]
16. Genetics in Drug Discovery.
Hubaud A; Singh AP
Trends Genet; 2021 Jul; 37(7):603-605. PubMed ID: 33902937
[TBL] [Abstract][Full Text] [Related]
17. Guest editors' note on special issue on application of estimand.
Seifu Y; Wang W
J Biopharm Stat; 2023 Jul; 33(4):401-402. PubMed ID: 37039452
[No Abstract] [Full Text] [Related]
18. Guest Editors' Note on the Special Issue
Lin J; Li Q
J Biopharm Stat; 2022 Jan; 32(1):1-3. PubMed ID: 35166642
[No Abstract] [Full Text] [Related]
19. Issue editors' notes. Special issue: universities in partnership: strategies for education, youth development, and community renewal.
Harkavy I; Hartley M
New Dir Youth Dev; 2009; 2009(122):1-2. PubMed ID: 19593808
[No Abstract] [Full Text] [Related]
20. Epigenetic-targeted drug discovery: from the guest editors.
Heightman T; Pope A
J Biomol Screen; 2011 Dec; 16(10):1135-6. PubMed ID: 22156584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
